Compare BHV & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BHV | MCRB |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.9M | 41.2M |
| IPO Year | 2002 | 2015 |
| Metric | BHV | MCRB |
|---|---|---|
| Price | $12.00 | $1.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 3.4K | ★ 82.3K |
| Earning Date | 01-01-0001 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $789,000.00 |
| Revenue This Year | N/A | $1,648.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.04 | $1.30 |
| 52 Week High | $15.15 | $29.98 |
| Indicator | BHV | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 51.35 | 23.16 |
| Support Level | $11.08 | N/A |
| Resistance Level | $12.99 | $2.26 |
| Average True Range (ATR) | 0.34 | 0.23 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 40.37 | 11.46 |
Blackrock Virginia Municipal Bond Trust is a perpetual closed-end municipal bond fund. Its objective of the fund is to provide current income exempt from regular Federal income taxes and Virginia personal income taxes.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.